Stock RPHM RENEO PHARMACEUTICALS, INC.
Add to a list
To use this feature you must be a member
Log inSign up

All News Reneo Pharmaceuticals, Inc.

Equities

RPHM

US75974E1038

Market Closed - Nasdaq
Other stock markets
 21:00:00 21/05/2024 BST 		5-day change 1st Jan Change
1.89 USD -0.53% Intraday chart for Reneo Pharmaceuticals, Inc. +16.67% +18.12%
05-16 Reneo Pharmaceuticals Insider Bought Shares Worth $639,578, According to a Recent SEC Filing MT
05-13 Reneo Pharmaceuticals to Merge With OnKure in All-Stock Deal -- Reneo Shares Rise MT

All News

Search
See the results
Unlock all the news on all businesses: Never miss an investment opportunity again!
100% Free Registration
Reneo Pharmaceuticals Insider Bought Shares Worth $639,578, According to a Recent SEC Filing
MT
RENEO PHARMACEUTICALS INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Merger of Reneo Pharmaceuticals, Inc. - RPHM
BU
STOCKHOLDER INVESTIGATION: The M&A Class Action Firm Announces An Investigation of Reneo Pharmaceuticals, Inc. - RPHM
PR
Shareholder Alert: Ademi LLP investigates whether Reneo Pharmaceuticals, Inc. has obtained a Fair Price in its Transaction with OnKure
PR
RPHM Alert: Monsey Firm of Wohl & Fruchter Investigating Proposed Merger of Reneo Pharmaceuticals With OnKure
AQ
RPHM Stock Alert: Halper Sadeh LLC Is Investigating Whether the Merger of Reneo Pharmaceuticals, Inc. Is Fair to Shareholders
BU
Reneo Pharmaceuticals to Merge With OnKure in All-Stock Deal -- Reneo Shares Rise
MT
Reneo Pharmaceuticals and OnKure Announce Proposed Merger
GL
OnKure, Inc. entered into an agreement to acquire Reneo Pharmaceuticals, Inc.
CI
Reneo Pharmaceuticals, Inc. announced that it expects to receive $65 million in funding from OnKure, Inc., RADIATE MERGER SUB II, LLC, Radiate Merger Sub I, Inc
CI
Reneo Pharmaceuticals, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024
CI
Reneo Pharmaceuticals Reports First Quarter 2024 Financial Results
GL
Reneo Pharmaceuticals, Inc. Reports Earnings Results for the Full Year Ended December 31, 2023
CI
Reneo Pharmaceuticals Reports Fourth Quarter And Full Year 2023 Financial Results And Business Update
GL
North American Morning Briefing : Tech in Focus on -2-
DJ
Concentra Biosciences, LLC submitted a non-binding proposal to acquire Reneo Pharmaceuticals, Inc. for $60 million.
CI
North American Morning Briefing : Stock Futures -2-
DJ
Reneo Pharmaceuticals, Inc.(NasdaqGM:RPHM) added to NASDAQ Biotechnology Index
CI
Ladenburg Thalmann Downgrades Reneo Pharmaceuticals to Neutral From Buy
MT
HC Wainwright Downgrades Reneo Pharmaceuticals to Neutral From Buy, Cuts Price Target to $1.50 From $30
MT
No results for this search
All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Search

Announcement Date

Since

Until

  1. Stock Market
  2. Equities
  3. RPHM Stock
  4. News Reneo Pharmaceuticals, Inc.